Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
Items 901–965 of 965
La signalisation insuline comme garant de la fonction barrière intestinale
Gueddouri, D. (2021) · theses.fr (ABES) · doi:10.70675/8371f5a7zb0c3z4f82z83e9z236d0eedb3f1
Role of environmental factors on intestinal barrier dysfunctions reported in obesity
Postal, B. G. (2019) · theses.fr (ABES) · doi:10.70675/4b9e7a12ze552z46bez8767z3241d10852d3
Short Chain Fatty Acids: A Novel Potential Target for Cadmium Hepatotoxicity
Wang, T., Yan, J., & Li, X. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70190
“…commonly characterized by impaired intestinal barrier function and dysregulation of the gut-liver axis, such as Type 2 diabetes and closely related conditions including NAFLD, alcoholic liver disease and primary sclerosing cholangitis (Albillos et al. 2020; Thaiss et al. 2018; Tilg et al. 2020).”
Metabolic Roles of Acyl Coenzyme A-Binding Protein (ACBP)/Diazepam Binding Inhibitor (DBI)
Joseph, A. (2021) · theses.fr (ABES) · doi:10.70675/b045685ezd444z4b46zb0f9z0e726ceac466
Rowe, M. C., Demuynck, M., Sharma, A., Nowell, C. J., Owyong, C., Perera, N., Tang, N. J., Veldhuis, N. A., Rajasekhar, P., Ritchie, R. H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.02.716104
“DM is often associated with increased intestinal permeability, thought to be due to a disrupted intestinal barrier 4–6 .”
Role of MAIT cells in virally-induced type 1 diabetes by Coxsackievirus B4
Rouland, M. (2022) · theses.fr (ABES) · doi:10.70675/71d8ae9cz623cz4299zaa75zde7eff17dcf2
Rôle d'ALPK1 dans la mise en place de l'obésité et des maladies métaboliques associées
Rolland, A. (2023) · theses.fr (ABES) · doi:10.70675/cd1ecd30z0c29z48adzb739z0806389628c0
Yang, X., Zhu, C., Liu, B., Yang, P. C., Cao, Z., Liang, J., Hu, J., Yu, Q., Zhong, Y., Du, W., et al. (2026) · Phytotherapy Research · doi:10.1002/ptr.70205
“It was reported that intestinal permeability plays a crucial role in metabolic homeostasis in vivo in recent years (König et al. 2016; Ray 2018; Thaiss et al. 2018).”
Dietary sugar intake as a risk factor for early-onset colorectal cancer in young New Zealanders
Dawson, K., Waddell, O., Frizelle, F. A., & Keenan, J. I. (2026) · New Zealand Medical Journal · doi:10.26635/6965.7378
Zhang, Q., Zheng, X., Chen, J., Zhang, Y., Li, J., Wang, Y., Pan, Y., Yu, F., Zhang, Z., Yang, H., et al. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108921
Klümpen, L., Mantri, A., Donkers, A., Seel, W., Stoffel‐Wagner, B., Coenen, M., Schmid, M., Weinhold, L., Grein, F., Newels, P., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2662687 · Cited by 1
“13,14 Given the increasing prevalence of noncommunicable diseases associated with an impaired gut barrier, 7,44 identifying cost-effective and easy-to-implement strategies to restore intestinal barrier function is crucial.”
Abdullayeva, C., Islamova, M., Алишеровна, З. Г., Akbarova, G. P., Буранова, Д., & Ирисов, Д. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.21s.10
Bacterial Extracellular Vesicles in Aging: Mechanisms and Therapeutic Prospects
Tan, J., Zubair, M., Zhang, L. Y., Liu, L.-P., Li, K., Wang, Y., Yan, Y., & Xu, W. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s597419
“Furthermore, obesity in MASLD patients significantly increases the risk of intestinal barrier damage, 173–177 a condition often compounded by a compromised hepatic clearance system.”
Chen, J., Tian, A., Huang, J., Wang, Z., & Wang, H. J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1800070
“…in fl ammation, and changes in gut microbiota composition (dysbiosis) induced by long-term hyperglycemia can disrupt the tight junctions between intestinal epithelial cells, thereby increasing intestinal permeability (Zhang et al., 2020; Thaiss et al., 2018; Mostafavi Abdolmaleky et al., 2024).”
Dhotre, S. V., Dhotre, P. S., Rao, A., & Nagoba, B. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i5.118333
Gut mucosal barrier: the frontline of bidirectional regulation of the gut-X axis
Xu, X. W., Hu, Y., Ruan, S., Peng, C., Han, T., Yan, P., Chan, F. K. L., & Li, J. (2026) · Medical Review · doi:10.1515/mr-2026-0009
“As a result, di ff erent dietary conditions may lead to di ff erent microbial metabolic outputs and di ff erent barrier responses, even before overt injury develops [102, 103, 131].”
Zhang, S., Cheng, X., Chen, L., & Wang, Y. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109243
Mei, X., Yang, Y., Wen, Y., Zhang, X., Li, Z., Yang, T., & Li, L. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1799829
“…the other hand, LPS-induced disruption of intestinal barrier integrity is accompanied by intestinal dysbiosis and low-grade inflammation, which collectively impair intestinal colonization resistance and thereby increase the risk of establishment and invasion by potential pathogens in the gut (95).”
Mitchell, R. A., Xu, M., Hudson, E., Taylor, M. S., Hill, B. G., McClain, C. J., & Song, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.07.729655
Gut microbiota and immune tolerance mechanisms in autoimmune diseases
Hossaini, F. (2025) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2025.28.2.3812
Feeding the invaders: how metabolic imbalance shapes infection and biofilm development
Mahajan, S., Macdowell, S., Mitchem, C. F., Alexander, E., & Wozniak, D. J. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuag029 · Cited by 2
“No-tably, metabolic diseases significantly increase the risk and severity of infections caused by enteric pathogens (Thaiss et al. 2018 , Yao et al. 2018 ).”
Toll-like receptor 4 knockout mice are protected against PMOS-like pathogenesis
Wiggins, K. D., Mundo, Z. D. D., Angulo, J. A. A., Naidu, N., Saba, A., Zhou, L., Garcia, C., Nguyen, C. M., Ujagar, N. S., Torre, J.-J. D. L., et al. (2026) · Reproduction · doi:10.1093/reprod/xaag081
Adverse Effects of Acute and Persistent Neonatal Hyperglycemia
Hay, W. W., & Alsweiler, J. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-29094-6_10
Han, H., Qian, Q., Wu, W., Yang, J., Zhou, J., & Sun, W. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.04048-25
“Hyperglycemia can cause intestinal barrier dysfunction, elevating the risk of intestinal infections (34).”
Maličević, U., Škrbić, R., & Agrawal, D. K. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05659-y · Cited by 1
“These findings are consistent with previous reports indicating that metabolic disturbances, particularly hyper-glycemia, may impair epithelial integrity and promote mucosal inflammation [ 15, 33, 34 ].”
Birabaharan, M., Kaelber, D. C., Nizet, V., & Zarrinpar, A. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag457
Insights Into Gut Microbiota and Metabolic Alterations in Type 1 Diabetes Mellitus
Fogagnolo, C., Ortiz, G. U., da Silva, A. S. R., & de Freitas, E. C. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70211
The Multi-Layered Effect of Panaxatriol Saponins in Preventing Diabetic Nephropathy in Mice
Guo, F., Lai, W., Chen, C., Dai, X., Wu, H., Xu, Z., Xing, A., Huang, R., & Ma, L. (2026) · Integrative Medicine in Nephrology and Andrology · doi:10.1097/imna-d-26-00027
Kundu, S., Islam, R., Sarkar, S., Chatterjee, O., Debnath, S., & Saha, L. (2026) · Genetics and Molecular Research · doi:10.4238/gcs7v027 · Cited by 1
Atunnise, A., Awoniran, P. G., Adebayo, O. L., Adewuyi, A., & Salau, B. A. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100527
Баходирович, Х. И., Babajonov, A. B., & Sаyidburxоnоv, S. (2026) · Frontiers in Surgery · doi:10.3389/fsurg.2026.1901971
“Glycated hemoglobin (HbA1c) summarizes three months of glycemic exposure and tracks the severity of diabetic autonomic neuropathy and intestinal barrier dysfunction (14, 15).”
InfluentialSierra-Bakhshi, C. G., Farr, L. A., Smith, M. E., Kalaskey, T. A., Perkins, K. G., Winter, M. G., Sigdel, S., Winter, S., & Bogomolnaya, L. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.14.744872
Muhia, M. W., Ochieng, R., & Migowa, A. (2026) · PeerJ · doi:10.7717/peerj.21601
“…to NEC are not fully understood; however, it is hypothesized that hyperglycemia induces excessive production of free radicals, which cause oxidative stress and damage to cells, including the intestinal barrier, potentially raising the risk of NEC ( Thaiss et al., 2018 ; Guo et al., 2020 ).”
Wang, Z., Wang, Y., Yan, P., Wang, X., & 俞兰秀 (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-05229-w
“This LPS-mediated “meta - bolic endotoxemia” is also a major contributing factor to metabolic diseases such as obesity and diabetes (Thaiss et al. 2018 ).”
Jovanović, M., Marković, B. S., Gajović, N., Jovanovic, M. M., Jocić, M., Stojanović, B., Corovic, I. F., Todorović, N., Jovanović, I., & Amedei, A. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.123426
Faiyaz, M., Yadav, Y. C., Kumar, R. C., Dubey, P. K., Kumari, P., & Singh, A. (2026) · Adolescencia e Saude · doi:10.67440/ahj.v21i6s.1894
“Hyperglycaemia is a plausible shared exposure because experimental studies show that it can directly alter intestinal epithelial integrity [11], glomerular endothelial glycocalyx properties [20] and blood-brain barrier biology [42].”
Cui, H., Nisar, A., Duan, Z., Mao, J., Zhu, H., Li, L., Cao, X., He, Y., & Li, W. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108443
Relación entre la microbiota intestinal y el desarrollo de enfermedades metabólicas
Vinces, J. A. V. (2026) · Polo del Conocimiento · doi:10.23857/pc.v11i2.12453
Genetic and microbial regulation of NOD2 signaling in homeostasis and disease
Wang, Y., Nie, J., Lin, G., He, X., & Zhou, H. (2026) · MedScience · doi:10.1007/s11684-026-1239-6
Nazari, A., Chinchankar, S., Ambite, I., Chaudhuri, A., Haq, F., Ahmadi, S., Gomes, I., Svanborg, C., & Tran, H. (2026) · Scientific Reports · doi:10.1038/s41598-026-71811-9
“Due to early onset type 1 diabetes, the mice rapidly develop chronic disease, a leaky gut syndrome and become emaciated ( 45 ).”
Lu, Y., Chai, M.-S., Lan, Q.-Y., Yang, Q.-M., Yang, F.-R., Xiao, T.-N., Kong, X.-W., Zhou, P., & Hua, H. (2026) · World Journal of Diabetes · doi:10.4239/wjd.124123
Tang, X., Gasaly, N., Chen, X., Toye, L., & de Vos, P. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107522
Yang, Y., Di, Y., Niu, Z., Deng, X., Luo, X., & Jia, L. (2026) · Food Research International · doi:10.1016/j.foodres.2026.120947
Interplay Between the Gut Microbiome and Oxidative Stress in Type 2 Diabetes
Kim, J.-W., Lee, Y., Kim, K., & Ko, S.-H. (2026) · Antioxidants · doi:10.3390/antiox15101278
“The microbiome–redox axis may contribute to diabetic complications through shared pathways: endothelial nitric oxide loss, mitochondrial injury, AGEs–RAGE signaling, inflammation, barrier dysfunction, altered immune regulation, and regulated cell death [4,5,7,8,14,33,48,52,53].”
InfluentialZhang, R., Wang, X., Zhao, Y., Wang, Z., Ran, X., Yu, X., & Li, K. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.7816959
Zhang, R., Wang, X., Zhao, Y., Wang, Z., Ran, X., Yu, X., & Li, K. (2026) · Angewandte Chemie · doi:10.1002/ange.7816959
Cai, Y., He, S., Zeng, F., & Liu, C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1954392
“Hyperglycemia-related barrier dysfunction (99), Western-diet/ NLRP3-dependent immune training (100), imidazole-propionate effects on insulin signaling (101) and wound-community associations (93, 94) address different questions.”
Venugopal, G., Jacob, A. A., Varghese, J. E., & Mattethra, G. C. (2026) · Comprehensive physiology · doi:10.1002/cph4.70278 · Cited by 1
Hajhamidiasl, L., Baş, M., Yılmaz, Ö., Ozer, S., Yılmaz, S., & Arslan, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1968504
“Chronic high-fat feeding disrupts gut barrier integrity and elevates circulating LPS via TLR4/NF-κ B activation (35, 36), and the observed reductions may reflect fasting-related improvements in gut barrier function rather than confirmed circadian–gut axis regulation.”
Immune dysregulation and immunoengineering strategies for type 2 diabetes
Sun, R., & Wang, C. (2026) · EngMedicine · doi:10.1016/j.engmed.2026.100173
Nutritional Modulation of Pathometabolic Pathways
Kumari, A., Mihooliya, K. N., & Singh, P. R. (2026) · Springer eBooks · doi:10.1007/978-3-032-30306-6_3
Kan, Y., Liu, Y., Zhao, L., Jiang, C., Lin, W., Pang, W., & Hu, J. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48101093
“Hyperglycemia can reprogram intestinal epithelial transcription, disrupt cell junctions, and increase the risk that microbial products enter the circulation [3].”
Algieri, F., Tanasković, N., Rincon, C. C., Notario, E., Braga, D., Pesole, G., Rusconi, R., Penna, G., & Rescigno, M. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10100097
Silvestri, A., Gil‐Gómez, A., Vitale, M., Braga, D., Demitri, C., Brescia, P., Madaghiele, M., Spadoni, I., Jones, B., Fornasa, G., et al. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10528693
Chen, H.-R., Li, J.-X., Zi-shan, F., Yang, Y.-F., Shi, Y., Li, H.-T., & Dong, S.-Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1943319
Targeting the gut-kidney axis: The potential of butyrate in the management of acute kidney injury
Choi, G. Y. S., Chen, H., Qin, N., Deng, K., Wang, Y., Wu, W. K. K., Chu, M. H. M., Wong, M. K. H., & Ho, K. M. (2026) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2026.10.004
Gutiérrez-González, V., Cavia-Sáiz, M., Múñiz, P., & Gerardi, G. (2026) · European Food Research and Technology · doi:10.1007/s00217-026-05352-w
Opposing microbiome-mediated axes link modifiable lifestyles to health and chronic diseases
Nagata, N., Wei, R., Kaneko, G., Nishijima, S., Aoki, R., Kojima, Y., Tamura, Y., Sugiyama, M., Hamabata, T., NAKAGAWA, T., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04744-5
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.